% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • insidetrack22 insidetrack22 Dec 4, 2012 12:32 PM Flag

    Above $12

    Imgn violent fluctuation on small volume traded. As PDUFA date approaches, expect even greater volatility in both options and stock price. Possible dilution is keeping IMGN from running into the $13+ by now. Institutiion holders still holding on which is a good sign. IMGN run up for the past 5 days may require a re-trace back around 12-11.90 to set a solid foundation and move up again. Broader market news will also drive IMGN to new level. If fiscal cliff issue resolves watch IMGN testing $13

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • IMGN just recently diluted at $16 and has $200MM+ in the bank. There should be no expectation of significant near-term dilution unless they buy a product, or company.

      SGEN is kicking IMGN's rear, the BOD, Junius, Perry all need to go!

      • 1 Reply to bioimmunomabman
      • I agree with you that IMGN greatest liability is their management. There does not seem to be anyone brilliant on the management team. Management owns very little IMGn shares (taking on little risks) while enriching themselves with options (taking all the rewards) at the expense of stock holders. Now they hire a CMO with a poor track record of staying in any one place long.

5.75-0.13(-2.21%)2:45 PMEDT